z-logo
open-access-imgOpen Access
The IκB Kinase Complex and NF-κB Actas Master Regulators of Lipopolysaccharide-Induced Gene Expressionand Control Subordinate Activation ofAP-1
Author(s) -
Daniel Krappmann,
Elmar Wegener,
Yoshiaki Sunami,
Meral Esen,
Andreas Thiel,
Benjamin Mordmüller,
Claus Scheidereit
Publication year - 2004
Publication title -
molecular and cellular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.14
H-Index - 327
eISSN - 1067-8824
pISSN - 0270-7306
DOI - 10.1128/mcb.24.14.6488-6500.2004
Subject(s) - biology , junb , iκb kinase , signal transduction , nf κb , microbiology and biotechnology , innate immune system , tlr4 , chemokine , psychological repression , transcription factor , iκbα , kinase , trif , toll like receptor , gene expression , immune system , immunology , gene , genetics
Toll-like receptors (TLRs) recognize conserved products of microbial pathogens to initiate the innate immune response. TLR4 signaling is triggered upon binding of lipopolysaccharides (LPS) from gram-negative bacteria. Using comparative gene expression profiling, we demonstrate a master regulatory role of IkappaB kinase (IKK)/NF-kappaB signaling for immediate-early gene induction after LPS engagement in precursor B cells. IKK/NF-kappaB signaling controls a large panel of gene products associated with signaling and transcriptional activation and repression. Intriguingly, the induction of AP-1 activity by LPS in precursor B cells and primary dendritic cells fully depends on the IKK/NF-kappaB pathway, which promotes expression of several AP-1 family members, including JunB, JunD, and B-ATF. In pre-B cells, AP-1 augments induction of a subset of primary NF-kappaB targets, as shown for chemokine receptor 7 (CCR7) and immunoglobulin kappa light chain. Thus, our data illustrate that NF-kappaB orchestrates immediate-early effects of LPS signaling and controls secondary AP-1 activation to mount an appropriate biological response.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here